IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$773M
AUM Growth
+$278M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
181
New
Increased
Reduced
Closed

Top Buys

1 +$33.1M
2 +$14.6M
3 +$14.3M
4
OLMA icon
Olema Pharmaceuticals
OLMA
+$13.5M
5
LLY icon
Eli Lilly
LLY
+$13.2M

Top Sells

1 +$53M
2 +$20.7M
3 +$16M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$13.6M
5
PTCT icon
PTC Therapeutics
PTCT
+$11.8M

Sector Composition

1 Healthcare 99.47%
2 Financials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYRA
126
DELISTED
LYRA THERAPEUTICS INC
LYRA
$65.2K 0.01%
21,161
JSPR icon
127
Jasper Therapeutics
JSPR
$28.6M
$44.1K 0.01%
24,093
-1,014
AEMD icon
128
Aethlon Medical
AEMD
$3.67M
$39.8K 0.01%
14,364
-1,002
RZLT icon
129
Rezolute
RZLT
$331M
$38.9K 0.01%
+16,479
PHGE icon
130
BiomX
PHGE
$16.1M
$36.4K ﹤0.01%
19,473
-1,210
AIRS icon
131
AirSculpt Technologies
AIRS
$181M
$32.5K ﹤0.01%
16,398
-1,553
TOVX icon
132
Theriva Biologics
TOVX
$11.8M
$23.6K ﹤0.01%
112,076
-7,955
SYBX
133
DELISTED
Synlogic
SYBX
$22.4K ﹤0.01%
19,966
-456
ANEB
134
DELISTED
Anebulo Pharmaceuticals
ANEB
$17.9K ﹤0.01%
17,736
-139,984
AMIX
135
Autonomix Medical
AMIX
$4.63M
$10.3K ﹤0.01%
18,688
-1,312
AKRO
136
DELISTED
Akero Therapeutics
AKRO
-206,854
ALT icon
137
Altimmune
ALT
$455M
0
ANAB icon
138
AnaptysBio
ANAB
$1.94B
-48,410
TVTX icon
139
Travere Therapeutics
TVTX
$3.77B
-190,781
UTHR icon
140
United Therapeutics
UTHR
$25.8B
0
VRDN icon
141
Viridian Therapeutics
VRDN
$1.51B
-245,518
XBI icon
142
State Street SPDR S&P Biotech ETF
XBI
$8.94B
0
ZYME icon
143
Zymeworks
ZYME
$2.07B
-72,787
ALMS
144
Alumis Inc
ALMS
$3.18B
0
MBX
145
MBX Biosciences
MBX
$1.6B
-48,071
ZBIO
146
Zenas BioPharma
ZBIO
$1.36B
0
UPB
147
Upstream Bio Inc
UPB
$544M
-161,113
PVLA
148
Palvella Therapeutics
PVLA
$1.86B
-64,746
MTSR
149
DELISTED
Metsera Inc
MTSR
0
TVRD
150
Tvardi Therapeutics
TVRD
$31.8M
0